Keyphrases
Therapeutic Effect
100%
Conditioned Medium
100%
Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSCs)
100%
Pulmonary Arterial Hypertension
100%
Mesenchymal Stem Cell-conditioned Medium
100%
Pulmonary Artery Hypertension
50%
Interleukin-1β
33%
Rat Model
33%
Mesenchymal Stem Cells
33%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
33%
Tail Vein
16%
Cell-to-cell
16%
Therapeutic Benefits
16%
Cell-based
16%
Therapeutic Use
16%
Potential Therapeutics
16%
Culture Media
16%
TUNEL
16%
Sprague-Dawley Rats
16%
Survival Rate
16%
Interventricular Septum
16%
Cell Therapy
16%
Tumorigenicity
16%
Respiratory Function
16%
In Vivo Data
16%
Terminal Deoxynucleotidyl Transferase dUTP Nick End Labeling
16%
Labeling Method
16%
Monocrotaline
16%
Left Ventricle
16%
CCL5
16%
3D Spheroids
16%
TUNEL Staining
16%
Lung Specimen
16%
Right Ventricle
16%
Ventricular Pressure
16%
Survival Chances
16%
Lung Tissue Damage
16%
Medicine and Dentistry
Pulmonary Hypertension
100%
Mesenchymal Stem Cell
100%
Therapy Effect
100%
Cord Blood
100%
Tissue Inhibitor of Metalloproteinase 1
40%
TUNEL Assay
40%
Interleukin 1
40%
Cell Therapy
40%
Lung
40%
Survival Rate
20%
Infusion
20%
Carcinogenicity
20%
Respiratory Physiology
20%
Tissue Injury
20%
Monocrotaline
20%
Left Ventricle
20%
DNA Nucleotidylexotransferase
20%
Tumor Spheroid
20%
Deoxyuridine
20%
Gamma Chemokine
20%
Labeling Technique
20%
Tail Vein
20%
Right Ventricle
20%
Interventricular Septum
20%
Heart Ventricle Pressure
20%
Pharmacology, Toxicology and Pharmaceutical Science
Pulmonary Hypertension
100%
Therapeutic Effect
100%
Tissue Inhibitor of Metalloproteinase 1
50%
Interleukin 1
50%
Rat Model
50%
Sprague Dawley Rat
25%
Survival Rate
25%
Gamma Chemokine
25%
Carcinogenicity
25%
Monocrotaline
25%
Tissue Injury
25%
DNA Nucleotidylexotransferase
25%
Deoxyuridine
25%
Moroxydine
25%